Several genes involved in pre-messenger RNA splicing, including SF3B1, U2AF1, SRSF2 and ZRSR2,2, 3, 4 have been shown to be mutated in over 50% of MDS patients, revealing a new leukemogenic pathway involving spliceosomal dysfunction. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.